Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2018 Earnings Conference Call Transcript

Nov 09, 2018 • 08:00 am ET


Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2018 Earnings Conference Call Transcript


Loading Event

Loading Transcript


Good morning, ladies and gentlemen and welcome to Axsome Therapeutics Third Quarter 2018 Financial Results Conference Call. Currently, all participants are in a listen-only mode. (Operator Instructions) As a reminder, today's conference call is being recorded. I would now like to turn the conference over to your host, Mark Jacobson, SVP of Operations at Axsome Therapeutics. Please go ahead.

Mark Jacobson

Thank you, operator. Good morning and thank you all for joining us on today's conference call to discuss Axsome Therapeutics 2018 third quarter financial results. A press release providing a corporate update and details of the Company's financial results for the third quarter ended September 30, 2018 crossed the wire a short time ago and is available on our website at (Forward Looking Cautionary Statements) Joining me on the call today are Dr. Herriot Tabuteau, CEO, Nick Pizzie, CFO and Dr. Cedric O'Gorman, SVP of Clinical Development and Medical Affairs. Dr. Tabuteau will first provide a pipeline update and a review of upcoming milestones, Cedric will then provide further detail on the progress of our clinical studies and Nick will review our third quarter financial results. We will then open the call for questions. I shall now turn over the call to Herriot.